Following is the balance sheet for Medtronic PLC for FY$2019$ ended April $26,2019.$

Consolidated Balance Sheet $($$ millions$)$ April $26,2019$

Current assets

Cash and cash equivalents $ $4,393$

Investments $5,455$

Accounts receivable, net $6,222$

Inventories, net $3,753$

Other current assets $2,144$

Total current assets $21,967$

Property, plant, and equipment, net $4,675$

Goodwill $39,959$

Other intangible assets, net $20,560$

Tax assets $1,519$

Other assets $1,014$

Total assets $$89,694$

Current liabilities

Current debt obligations $ $838$

Accounts payable $1,953$

Accrued compensation $2,189$

Accrued income taxes $567$

Other accrued expenses $2,925$

Total current liabilities $8,472$

Long$-$term debt $24,486$

Accrued compensation and retirement benefits $1,651$

Accrued income taxes $2,838$

Deferred tax liabilities $1,278$

Other liabilities $757$

Total liabilities $39,482$

Shareholders$$ equity

Ordinary shares $0$

Additional paid$-$in capital $26,532$

Retained earnings $26,270$

Accumulated other comprehensive loss $(2,711)$

Total shareholders$$ equity $50,091$

Noncontrolling interests $121$

Total equity $50,212$

Total liabilities and equity $$89,694$

Use the following assumptions to forecast the company$$s balance sheet for FY$2020.$

Forecasted FY$2020$ net income $$4,927$ million

Forecasted FY$2020$ net sales $$33,002$ million

Investments No change

Accounts receivable, less allowance $20\mathrm{.}4\%$ of net sales

Inventories, net $12\mathrm{.}3\%$ of net sales

Other current assets $7\%$ of net sales

Goodwill No change

Tax assets $5\%$ of net sales

Other assets $3\mathrm{.}3\%$ of net sales

Accounts payable $6\mathrm{.}4\%$ of net sales

Accrued compensation $($current liability$)7\mathrm{.}2\%$ of net sales

Accrued compensation and retirement benefits $($noncurrent liability$)$ No change

Accrued income taxes $($current liability$)1\mathrm{.}9\%$ of net sales

Other accrued expenses $9\mathrm{.}6\%$ of net sales

Accrued income taxes $($noncurrent liability$)9\mathrm{.}3\%$ of net sales

Deferred tax liabilities $4\mathrm{.}2\%$ of net sales

Other liabilities $2\mathrm{.}5\%$ of net sales

Ordinary shares No change

Accumulated other comprehensive loss No change

Net income attributable to noncontrolling interest $$19$ million

Dividends in FY$2020$ $$2,853$ million

CAPEX $3\mathrm{.}7\%$ of net sales

Depreciation expense in FY$2020$ $$950$ million

Amortization expense in FY$2020$ $$1,914$ million

Debt due in FY$2020$ $$838$ million

Debt due in FY$2021$ $$2,058$ million

MEDTRONIC PLC

Forecasted Balance Sheet

April $2020$

Current assets

Cash and cash equivalents Answer

$7,227$

Investments Answer

$5,455$

Accounts receivable, net Answer

$6,732$

Inventories, net Answer

$4,059$

Other current assets Answer

$2,310$

Total current assets Answer

$25,783$

Property, plant, and equipment, net Answer

$4,859$

Goodwill Answer

$39,959$

Other intangible assets, net Answer

$18,646$

Tax assets Answer

$1,650$

Other assets Answer

$1,089$

Total assets Answer

$91,986$

Current liabilities

Current debt obligations Answer

$2,058$

Accounts payable Answer

$2,112$

Accrued compensation Answer

$2,376$

Accrued income taxes Answer

$627$

Other accrued expenses Answer

$3,168$

Total current liabilities Answer

$10,341$

Long$-$term debt Answer

$22,428$

Accrued compensation and retirement benefits Answer

$1,651$

Accrued income taxes Answer

$3,069$

Deferred tax liabilities Answer

$1,386$

Other liabilities Answer

$825$

Total liabilities Answer

$39,700$

Shareholders$$ equity

Ordinary shares Answer

$0$

Additional paid$-$in capital Answer

$26,532$

Retained earnings Answer

$28,325$

Accumulated other comprehensive loss Answer

$(2,711)$

Total shareholders$$ equity Answer

$52,146$

Noncontrolling interests Answer

$140$

Total equity Answer

$52,286$

Total liabilities and equity Answer

$91,986$